Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis

Life Sciences

Volumn 73, Issue 16, 2003, Pages 2047-2058

  Tsang, W P ^a   Chau, Sophia P Y ^a   Kong, S K ^a   Fung, K P ^a   Kwok, T T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Doxorubicin; p53 independent; Reactive oxygen species

Indexed keywords

CASPASE 3; CATALASE; CYTOCHROME C; DNA; DOXORUBICIN; HYDROGEN PEROXIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; OSTEOSARCOMA CELL; PROTEIN DEGRADATION; PROTEIN SECRETION; UPREGULATION;

EID: 0042705073     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00566-6     Document Type: Article

References (30)

1. Abeysinghc R.D., Greene B.T., Haynes R., Willingham M.C., Turner J., Planalp R.P., Brechbiel M.W., Torti F.M., Torti S.V. p53-independent apoptosis mediated by tachpyridine, an anticancer iron chelator. Carcinogenesis. 22:2001;1607-1614.
2. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.J., Mazzei G., Maundrell K., Gambale F., Sadoul R., Martinou J.C. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:1997;370-372.
3. Bennett M., MacDonald K., Chan S.W., Luzio J.P., Simari R., Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 282:1998;290-293.
4. Biroccio A., Benassi B., Amodei S., Gabellini C., Del Bufalo D., Zupi G. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Molecular Pharmacology. 60:2001;174-182.
5. Cai Z., Lin M., Wuchter C., Ruppert V., Dorken B., Ludwig W.D., Karawajew L. Apopototic response to homoharringtonine in human wt p53 leukemia cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation. Leukemia. 15:2001;567-574.
6. Chen Y.C., Lin-shiau S.Y., Lin J.K. Involvement of reactive oxygen species and caspase-3 activation in arsenite-induced apoptosis. Journal of Cellular Physiology. 177:1998;324-333.
7. Datta K., Babbar P., Srivastava T., Sinha S., Chattopadhyay P. p53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress. International Journal of Biochemical and Cellular Biology. 34:2002;148-157.
8. Dietze E.C., Caldwell L.E., Grupin S.L., Mancini M., Seewaldt V.L. Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization. Journal of Biological Chemistry. 276:2001;5384-5394.
9. Eischen C.M., Packham G., Nip J., Fee B.E., Hiebert S.W., Zambetti G.P., Cleveland J.L. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene. 20:2001;6983-6993.
10. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:1994;539-542.
11. Fleury C., Mignotte B., Vayssiere J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 84:2002;131-141.
12. Hampton M.B., Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Letter. 414:1997;552-556.
13. Henkels K.M., Turchi J.J. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Research. 59:1999;3077-3083.
14. Huang C., Li J., Zheng R., Cui K. Hydrogen peroxide-induced apoptosis in human hepatoma cells is mediated by CD95(APO-1/Fas) receptor/ligand system and may involve activation of wild-type p53. Molecular Biology Reports. 27:2000;1-11.
15. Juin P.H., Tremblais M.T., LeCabelles M.T., Gregoire M., Meflah K., Vallette F.M. Potentiation of apoptosis by mitochondria in cell-free system. Biochemical and Biophysical Research Communications. 253:1998;185-191.
16. Kita T., Nakashima T. A recent trend in methamphetamine-induced neurotoxicity. Nihon Shinkei Seishin Yakurigaku Zasshi. 22:2002;35-47.
17. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
18. Matsui Y., Tsuchida Y., Keng P.C. Effects of p53 mutations on cellular sensitivity to ionizing radiation. American Journal of Clinical Oncology. 24:2001;486-490.
19. Nair J., Traganos F., Tse-Dinh Y.C. Differential effect of camptothecin treatment on topoisomerase II alpha expression in ML-1 and HL-60 leukemia cell lines. Anticancer Research. 20:2000;4183-4188.
20. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
21. Ravagnan L., Roumier T., Kroemer G. Mitochondrial, the killer organelles and their weapons. Journal of Cellular Physiology. 192:2002;131-137.
22. Rohn T.A., Wagenknecht B., Roth W., Naumann U., Gulbins E., Krammer P.H., Walczak H., Weller M. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release. Oncogene. 20:2001;4127-4137.
23. Sakamuro D., Eviner V., Elliott K.J., Showe L., White E., Prendergast G.C. c-myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 11:1995;2148-2411.
24. Sawa H., Kobayashi T., Mukai K., Zhang W., Shiku H. Bax overexpression enhances cytochrome c release from mitochondria and sensitizes KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis. International Journal of Oncology. 16(4):2000;745-749.
25. Shapiro G.I., Koestner D.A., Matranga C.B., Rollins B.J. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Clinical Cancer Research. 10:1999;2925-2938.
26. Sheikh M.S., Burn T.F., Huang Y., Wu G.S., Amundson S., Brook K.S., Fornace A.J. Jr., El-Deiry W.S. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Research. 58:1998;1593-1598.
27. Skulachev V.P. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Letter. 423(3):1998;275-280.
28. Vrablic A.S., Albright C.D., Craciunescu C.N., Salganik R.I., Zeisel S.H. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes. The FASEB Journal. 15:2001;1739-1744.
29. Yin C., Knudson C.M., Korsmeyer S.J., Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 385:1997;637-640.
30. Zamzami N., Marzo I., Susin S.A., Brenner C., Larochette N., Marchetti P., Reed J.K., Kroemer G. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of bcl-2 by enforcing mitochondrial permeability transition. Oncogene. 16:1998;1055-1063.